Synthesis of the heteroarotinoid ethyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-YL)-1- propenyl]benzoate-9,10,11,20-14C4
✍ Scribed by Prasanna Sunthankar; K. Darrell Berlin; Eldon C. Nelson
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 329 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A synthesis of ethyl (E)‐4‐[2‐(3,4‐dihydro‐4,4‐dimethyl‐2__H__‐1‐benzopyran‐6‐yl)‐1‐propenyl]benzoate‐9,10,11,20‐^14^C4 (1) is described via a multistep procedure similar to that used to obtained the unlabelled compound 2. The latter has shown good activity in several assays compared to the standard trans‐retinoic acid (3). Treatment of methyl 3‐phenoxypropionate (4) with methylmagnesium iodide (obtained from H~3~^14^C‐I) yielded the labelled tertiary alcohol 5. Cyclization of the alcohol 5 occurred in the presence of AlCl~3~ in nitromethane to give 4,4‐dimethylchroman (6). Acetylation of 6 with H~3~C^14^C(O)Cl produced ketone 7 labelled at three carbons. Reduction of the carbonyl group in 7 was effected with LiAlH~4~ and gave alcohol 8. Phosphorylation with triphenylphosphine hydrobromide in methanol led to the corresponding phosphonium salt 9. Addition of n‐butyllithium to 9 in ether at −78°C generated the expected Wittig reagent in situ, and to this was added labelled ethyl 4‐formylbenzoate [C~2~H~5~O~2~^14^C‐C~6~H~4~‐CHO] (10). Workup, followed by chromatography of the oily product, afforded a solid. Recrystallization (abs. ethanol) gave 1 which was identical to 2 in terms of spectral data and melting point. The specific activity was determined to be 0.15 μCi/mg.
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v
The carbon-I4 labelled compound ( 5 ) of 2-[4-(diphenylmethy1)-l -piperazinyl]ethyl methyl (?)-I ,$-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride (CV-4093 (2HCI)) was synthesized for the study of its metabolism and distribution in test animals. Starting from the co